Abstract
Platelets are an essential component of the hemostatic system in non-pregnant and more so in pregnant women. Low platelet counts during pregnancy can be harmful both to the mother and the fetus and can lead to several complications during and after pregnancy. Studies in mice have demonstrated that platelets conduct important functions that ultimately contribute to normal development of the embryo and successful outcome of the pregnancy. While embryonic platelets are dispensable during intrauterine development, they are strictly required during the neonatal period to control hemostasis and closure of the ductus arteriosus. Conversely, maternal platelets—in addition to hemostasis—also regulate placental function, potentially through platelet-released mediators, and studies in mice suggest that increased platelet activation contributes towards the pathogenesis of hypertensive disorders of pregnancy (HDP). Maternal platelet activation has important but poorly defined functions at the feto-maternal vascular bed. This is exemplified by the crucial role of platelets for placental and developmental failure due to defects in the TM-EPCR coagulation system. The relevance of increased platelet activation for HDP is supported by the beneficial effects of inhibition of platelet activation on pregnancy outcome in women with HDP, as shown in large meta-analyses. However, there remains limited and meager mechanistic information on platelet associated pregnancy disorders, which coupled with the challenges of conducting clinical trials in pregnant women is restricting the development of novel therapeutics targeting platelet dependent patho-mechanisms during pregnancy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost 92(4):776–786
American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 122(5):1122–1131
An J, Waitara MS, Bordas M, Arumugam V, Hoffmann RG, Petrich BG, Sinha U, North PE, Sood R (2013) Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. Blood 121(11):2127–2134
Beardsley DS (2002) Pathophysiology of immune thrombocytopenic purpura. Blood Rev 16(1):13–14
Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P (2000) Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 95(1):29–33
Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, D'Ercole C, Dignat-George F (2003) Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 89(3):486–492
Burrows RF, Kelton JG (1993a) Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 329(20):1463–1466
Burrows RF, Kelton JG (1993b) Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 48(12):781–788
Camerer E, Duong DN, Hamilton JR, Coughlin SR (2004) Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency. Blood 103(1):152–154
Camerer E, Barker A, Duong DN, Ganesan R, Kataoka H, Cornelissen I, Darragh MR, Hussain A, Zheng YW, Srinivasan Y, Brown C, Xu SM, Regard JB, Lin CY, Craik CS, Kirchhofer D, Coughlin SR (2010) Local protease signaling contributes to neural tube closure in the mouse embryo. Dev Cell 18(1):25–38
Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346(13):995–1008
Coata G, Frusca T, Baranzelli D, Cosmi EV, Di Renzo GC, Anceschi MM (1992) Abnormal platelet lipid membrane composition in pregnancy induced hypertension. J Perinat Med 20(2):123–127
Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407(6801):258–264
De Santis M, De Luca C, Mappa I, Cesari E, Mazza A, Quattrocchi T, Caruso A (2011) Clopidogrel treatment during pregnancy: a case report and a review of literature. Intern Med 50(16):1769–1773
Duley L, Henderson-Smart D, Knight M, King J (2001) Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 322(7282):329–333
Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L, Rudelius M, Seidl S, Kremmer E, Emambokus NR, von Bruehl ML, Frampton J, Isermann B, Genzel-Boroviczeny O, Schreiber C, Mehilli J, Kastrati A, Schwaiger M, Shivdasani RA, Massberg S (2010) Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16(1):75–82
Erlich J, Parry GC, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N (1999) Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A 96(14):8138–8143
Fay RA, Hughes AO, Farron NT (1983) Platelets in pregnancy: hyperdestruction in pregnancy. Obstet Gynecol 61(2):238–240
Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J, Dan K, Omine M, Mizoguchi H (2002) Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 75(4):426–433
Galanaud JP, Cochery-Nouvellon E, Alonso S, Chauleur C, Mercier E, Lissalde-Lavigne G, Fabbro-Peray P, Reny JL, Mares P, Dauzat M, Quere I, Gris JC (2010) Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep vein thrombosis during pregnancy. J Thromb Haemost 8(4):707–713
Gernsheimer TB (2012) Thrombocytopenia in pregnancy: is this immune thrombocytopenia or…? Hematol Am Soc Hematol Educ Program 2012:198–202
Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, Esmon CT (2002) Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem 277(45):43335–43343
Hammerman C, Kaplan M (2001) Comparative tolerability of pharmacological treatments for patent ductus arteriosus. Drug Saf 24(7):537–551
Harlow FH, Brown MA, Brighton TA, Smith SL, Trickett AE, Kwan YL, Davis GK (2002) Platelet activation in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 187(3):688–695
Hayashi M, Kiumi F, Mitsuya K (1999) Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia. Am J Med Sci 318(2):115–121
Healy AM, Rayburn HB, Rosenberg RD, Weiler H (1995) Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci U S A 92(3):850–854
Huppertz B (2008) Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 51(4):970–975
Hutt R, Ogunniyi SO, Sullivan MH, Elder MG (1994) Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol 83(1):146–149
Isermann B, Hendrickson SB, Hutley K, Wing M, Weiler H (2001) Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128(6):827–838
Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, Mackman N, Weiler H (2003) The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 9(3):331–337
Jaremo P, Lindahl TL, Lennmarken C, Forsgren H (2000) The use of platelet density and volume measurements to estimate the severity of pre-eclampsia. Eur J Clin Invest 30(12):1113–1118
Juan P, Stefano G, Antonella S, Albana C (2011) Platelets in pregnancy. J Prenat Med 5(4):90–92
Kadir RA, McLintock C (2011) Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost 37(6):640–652
Kashif M, Hellwig A, Kolleker A, Shahzad K, Wang H, Lang S, Wolter J, Thati M, Vinnikov I, Bierhaus A, Nawroth PP, Isermann B (2011) p45NF-E2 represses Gcm1 in trophoblast cells to regulate syncytium formation, placental vascularization and embryonic growth. Development 138(11):2235–2247
Kashif M, Hellwig A, Hashemolhosseini S, Kumar V, Bock F, Wang H, Shahzad K, Ranjan S, Wolter J, Madhusudhan T, Bierhaus A, Nawroth P, Isermann B (2012) Nuclear factor erythroid-derived 2 (Nfe2) regulates JunD DNA-binding activity via acetylation: a novel mechanism regulating trophoblast differentiation. J Biol Chem 287(8):5400–5411
Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93(10):1049–1059
Kim SY, Ryu HM, Yang JH, Kim MY, Ahn HK, Lim HJ, Shin JS, Woo HJ, Park SY, Kim YM, Kim JW, Cho EH (2004) Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J Korean Med Sci 19(5):688–692
Knight M, Duley L, Henderson-Smart DJ, King JF (2000) Antiplatelet agents for preventing and treating pre-eclampsia. Cochrane Database Syst Rev 2, CD000492
Laude I, Rongieres-Bertrand C, Boyer-Neumann C, Wolf M, Mairovitz V, Hugel B, Freyssinet JM, Frydman R, Meyer D, Eschwege V (2001) Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost 85(1):18–21
Li W, Zheng X, Gu JM, Ferrell GL, Brady M, Esmon NL, Esmon CT (2005) Extraembryonic expression of EPCR is essential for embryonic viability. Blood 106(8):2716–2722
Louden KA, Broughton Pipkin F, Heptinstall S, Fox SC, Mitchell JR, Symonds EM (1991) Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol 98(12):1239–1244
Magee LA, Helewa M, Moutquin JM, von Dadelszen P, Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars (2008) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30(3 Suppl):S1–S48
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Committee SHG (2014) Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 36(7):575–576
Malassine A, Frendo JL, Evain-Brion D (2003) A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9(6):531–539
Marques FK, Campos FM, Filho OA, Carvalho AT, Dusse LM, Gomes KB (2012) Circulating microparticles in severe preeclampsia. Clin Chim Acta 414:253–258
Mitchell SC, Korones SB, Berendes HW (1971) Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43(3):323–332
Morrison R, Crawford J, MacPherson M, Heptinstall S (1985) Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemost 54(3):607–611
Nadar S, Lip GY (2004) Platelet activation in the hypertensive disorders of pregnancy. Expert Opin Investig Drugs 13(5):523–529
Nelson-Piercy C (1997) Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol 11(3):489–509
Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L (1997) Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 78(1):386–391
Offermanns S, Toombs CF, Hu YH, Simon MI (1997) Defective platelet activation in G alpha(q)-deficient mice. Nature 389(6647):183–186
Olson GL, Saade GR, Buhimschi I, Chwalisz K, Garfield RE (1999) The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia. Am J Obstet Gynecol 181(3):638–641
Omri A, Delaloye JF, Andersen H, Bachmann F (1989) Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost 61(1):55–56
Palumbo JS, Zogg M, Talmage KE, Degen JL, Weiler H, Isermann BH (2004) Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction. J Thromb Haemost 2(8):1368–1379
Patti G, De Caterina R, Abbate R, Andreotti F, Biasucci LM, Calabrò P, Cioni G, Davì G, Di Sciascio G, Golia E, Golino P, Malatesta G, Mangiacapra F, Marcucci R, Nusca A, Parato VM, Pengo V, Prisco D, Pulcinelli F, Renda G, Ricottini E, Ruggieri B, Santilli F, Sofi F, Zimarino M; Working Group on Thrombosis of the Italian Society of Cardiology (2014) Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A ‘state-of-the-art’ paper. Eur Heart J 35(33):2213–2223b
Pekonen F, Rasi V, Ammala M, Viinikka L, Ylikorkala O (1986) Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 43(5):553–560
Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM (2008) Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci 15(4):374–381
Rabini RA, Salvolini E, Staffolani R, Pugnaloni A, Simonelli L, Biagini G, Cester N, Garzetti GG, Mazzanti L (1995) Biochemical-morphological modifications of platelet membranes during pregnancy-induced hypertension. Exp Mol Pathol 63(3):175–185
Ramsey EM (1981) The story of the spiral arteries. J Reprod Med 26(8):393–399
Sainio S, Kekomaki R, Riikonen S, Teramo K (2000) Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 79(9):744–749
Santiago-Diaz P, Arrebola-Moreno AL, Ramirez-Hernandez JA, Melgares-Moreno R (2009) Platelet antiaggregants in pregnancy. Rev Esp Cardiol 62(10):1197–1198
Sato Y, Fujiwara H, Zeng BX, Higuchi T, Yoshioka S, Fujii S (2005) Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries. Blood 106(2):428–435
Schwartz RS (2007) Immune thrombocytopenic purpura--from agony to agonist. N Engl J Med 357(22):2299–2301
Shivdasani RA, Orkin SH (1995) Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci U S A 92(19):8690–8694
Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJ, Orkin SH (1995) Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81(5):695–704
Sood R, Zogg M, Westrick RJ, Guo YH, Kerschen EJ, Girardi G, Salmon JE, Coughlin SR, Weiler H (2007) Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. J Exp Med 204(5):1049–1056
Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H (2008) Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood 112(3):585–591
Stavrou E, McCrae KR (2009) Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am 23(6):1299–1316
Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter S, Degen JL (1995) Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 9(16):2020–2033
Tada T, Kishimoto H (1990) Ultrastructural and histological studies on closure of the mouse ductus arteriosus. Acta Anat (Basel) 139(4):326–334
Tannetta DS, Hunt K, Jones CI, Davidson N, Coxon CH, Ferguson D, Redman CW, Gibbins JM, Sargent IL, Tucker KL (2015) Syncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet function. PLoS One 10(11), e0142538
Taylor RN, de Groot CJ, Cho YK, Lim KH (1998) Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 16(1):17–31
Vanwijk MJ, Svedas E, Boer K, Nieuwland R, Vanbavel E, Kublickiene KR (2002) Isolated microparticles, but not whole plasma, from women with preeclampsia impair endothelium-dependent relaxation in isolated myometrial arteries from healthy pregnant women. Am J Obstet Gynecol 187(6):1686–1693
Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG (2003) A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 102(13):4306–4311
Wright JF, Blanchette VS, Wang H, Arya N, Petric M, Semple JW, Chia WK, Freedman J (1996) Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol 95(1):145–152
Xu MJ, Matsuoka S, Yang FC, Ebihara Y, Manabe A, Tanaka R, Eguchi M, Asano S, Nakahata T, Tsuji K (2001) Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac. Blood 97(7):2016–2022
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Kohli, S., Isermann, B. (2017). The Role of Platelets During Development and Reproduction. In: Gresele, P., Kleiman, N., Lopez, J., Page, C. (eds) Platelets in Thrombotic and Non-Thrombotic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-47462-5_36
Download citation
DOI: https://doi.org/10.1007/978-3-319-47462-5_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47460-1
Online ISBN: 978-3-319-47462-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)